Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wuxuan Mei

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Oncology|April 11, 2022
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?Yan Peng, Yuanyuan Wang, Cheng Zhou, et al.
Frontiers in Oncology|September 19, 2022
Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunitiesQingqing Xie, Pengfei Zhang, Yuanyuan Wang, et al.
Critical Reviews in Oncology/Hematology|February 12, 2026
FGFR-Driven Lung Cancer: Dissecting Resistance and Exploring Therapeutic AvenuesPengfei Zhang, Wuxuan Mei, Yueru Yao, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 17, 2025
Decoding the epigenetic landscape: ctDNA methylation as a game-changer in hepatocellular carcinoma managementDexin Yang, Yueru Yao, Fenfang Gui, et al.
Frontiers in Pharmacology|October 8, 2021
Atractyloside Protect Mice Against Liver Steatosis by Activation of Autophagy <i>via</i> ANT-AMPK-mTORC1 Signaling PathwayPengfei Zhang, Xinyu Cheng, Huimin Sun, et al.
Journal of Translational Medicine|April 3, 2023
Phase separation in cancer at a glanceQingqing Xie, Jiejuan Cheng, Wuxuan Mei, et al.
Frontiers in Nutrition|January 5, 2023
Dietary intake of fructose increases purine <i>de novo</i> synthesis: A crucial mechanism for hyperuricemiaPengfei Zhang, Huimin Sun, Xinyu Cheng, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Oncology|April 11, 2022
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?Yan Peng, Yuanyuan Wang, Cheng Zhou, et al.
Frontiers in Oncology|September 19, 2022
Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunitiesQingqing Xie, Pengfei Zhang, Yuanyuan Wang, et al.
Critical Reviews in Oncology/Hematology|February 12, 2026
FGFR-Driven Lung Cancer: Dissecting Resistance and Exploring Therapeutic AvenuesPengfei Zhang, Wuxuan Mei, Yueru Yao, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 17, 2025
Decoding the epigenetic landscape: ctDNA methylation as a game-changer in hepatocellular carcinoma managementDexin Yang, Yueru Yao, Fenfang Gui, et al.
Frontiers in Pharmacology|October 8, 2021
Atractyloside Protect Mice Against Liver Steatosis by Activation of Autophagy <i>via</i> ANT-AMPK-mTORC1 Signaling PathwayPengfei Zhang, Xinyu Cheng, Huimin Sun, et al.
Journal of Translational Medicine|April 3, 2023
Phase separation in cancer at a glanceQingqing Xie, Jiejuan Cheng, Wuxuan Mei, et al.
Frontiers in Nutrition|January 5, 2023
Dietary intake of fructose increases purine <i>de novo</i> synthesis: A crucial mechanism for hyperuricemiaPengfei Zhang, Huimin Sun, Xinyu Cheng, et al.
Pageof 2